Global Morpho Pharma is a French start-up company created in 2018 that aims at developing and distributing GMP-grade radioisotopes. We are developing innovative equipment and building efficient supply chains to enable our partners worldwide to manufacture or source nca Lu-177 and other radioisotopes of interest.
We are dedicated to improving the accessibility and supply security of medical radioisotopes for the benefit of patients by providing convenient solutions to the rapidly expanding nuclear medicine ecosystem.
The Blue Morpho (Morpho menelaus) is not only one of the largest butterflies, but a symbol of beauty, perfection and freedom. Its iridescent metallic blue wings are reminiscent of the blue color of the Cherenkov Effect, the only visible way to recognize radioactivity.
Five experts of the nuclear medicine field came together with a common vision about the future of radiotherapeutics and radiotheranostics. With a cumulated experience of over 100 years in nuclear medicine, this group anticipated a very fast growth of this field and identified the challenges posed by industrialization of radiopharmaceutical drug manufacturing. Success of this industry, one of the most complex and regulated industry in the world, requires manufacturing quality, supply security and distribution reliability. The foundation of Global Morpho Pharma aims to address the needs of the pharmaceutical industry by improving the accessibility and supply security of medical radioisotopes for the benefit of patients.